# Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer

> **NCT02000193** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 58 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** fulvestrant

## Key facts

- **NCT ID:** NCT02000193
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-11
- **Primary completion:** 2016-04
- **Final completion:** 2018-12
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2018-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02000193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02000193, "Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02000193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*